Research / AZTA / Fundamental state Inspectable configuration
State dimensions Filing 0001628280-26-054295 General Corporate
Capex intensity 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.12% · OPTIONAL · VALID
Operating cash generation 25th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
0.90% · OPTIONAL · VALID
Revenue growth 80th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
11.97% · CORE · VALID
Inventory pressure 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
49.06% · OPTIONAL · VALID
Gross margin 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
44.89% · CORE · VALID
Operating margin 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-2.59% · CORE · VALID
R&D intensity 75th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
5.49% · OPTIONAL · VALID
SBC intensity 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
2.91% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 48 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 5.11%
Current 4.12%
Delta -0.99% Cash Generation Decreased
Previous 9.33%
Current 0.90%
Delta -8.44% Growth Increased
Previous 0.96%
Current 11.97%
Delta 11.01% Inventory Pressure Decreased
Previous 54.22%
Current 49.06%
Delta -5.16% Margin Increased
Previous 42.84%
Current 44.89%
Delta 2.05% Profitability Increased
Previous -114.50%
Current -2.59%
Delta 111.91% R And D Intensity Decreased
Previous 6.51%
Current 5.49%
Delta -1.02% Sbc Intensity Decreased
Previous 4.33%
Current 2.91%
Delta -1.42% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Dec 31, 2025
Similarity 75%
Compared 8 dimensions
Coverage 100% Growth 30.0 · Margin 10.0 · Profitability 30.0 · Sbc Intensity 5.0 · Capex Intensity 5.0 · Cash Generation 45.0 · R And D Intensity 20.0 · Inventory Pressure 25.0 Dec 31, 2017
Similarity 70%
Compared 7 dimensions
Coverage 88% Growth 24.4 · Margin 50.0 · Profitability 15.0 · Sbc Intensity 9.2 · Capex Intensity 20.8 · R And D Intensity 44.2 · Inventory Pressure 23.8 Jun 30, 2018
Similarity 64%
Compared 8 dimensions
Coverage 100% Growth 16.4 · Margin 43.3 · Profitability 15.0 · Sbc Intensity 26.7 · Capex Intensity 43.3 · Cash Generation 19.4 · R And D Intensity 68.3 · Inventory Pressure 16.7 Jun 30, 2017
Similarity 63%
Compared 6 dimensions
Coverage 75% Margin 50.0 · Profitability 15.0 · Sbc Intensity 3.6 · Capex Intensity 0.9 · R And D Intensity 75.0 · Inventory Pressure 6.4 Jun 30, 2024
Similarity 60%
Compared 8 dimensions
Coverage 100% Growth 45.0 · Margin 30.0 · Profitability 55.0 · Sbc Intensity 15.0 · Capex Intensity 10.0 · Cash Generation 5.0 · R And D Intensity 65.0 · Inventory Pressure 45.0 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.